Observations placeholder
Treanda
Identifier
020232
Type of Spiritual Experience
Background
A description of the experience
Bendamustine (INN, trade names Treakisym, Ribomustin, Levact and Treanda; also known as SDX-105) is a nitrogen mustard used in the treatment of chronic lymphocytic leukemia and lymphomas. It belongs to the family of drugs called alkylating agents. It is also being studied for the treatment of sarcoma. It is also being investigated in phase II trials for the non-cancer treatment of AL amyloidosis.
Adverse effects
Common adverse reactions are typical for the class of nitrogen mustards, and include nausea, fatigue, vomiting, diarrhea, fever, constipation, loss of appetite, cough, headache, unintentional weight loss, difficulty breathing, rashes, and stomatitis, as well as immunosuppression, anemia, and low platelet counts. Notably, this drug has a low incidence of hair loss (alopecia) unlike most other chemotherapy drugs.
On Dec, 20, 2016 3,762 people reported to have side effects when taking Treanda.
Among them, 3 people (0.08%) have Hallucination
On Jan, 27, 2016: 2,580 people reported to have side effects when taking Treanda. Among them, 66 people (2.56%) have Death.
Time on Treanda when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 60.00% | 33.33% | 0.00% | 0.00% | 6.67% | 0.00% | 0.00% |